Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What does patent wo2004033447a1 claim about the chroman imidazolethione aminoethyl compound?

See the DrugPatentWatch profile for compound

What chemical does WO2004033447A1 cover?

WO2004033447A1 is a patent application about compounds that include a “chroman imidazolethione aminoethyl” structural motif (i.e., an aminoethyl-substituted chroman-linked imidazolethione scaffold), along with related substituted analogs. It claims this class of compounds as specific, defined chemical entities rather than only general methods or uses. [1]

What does the patent claim that the “chroman imidazolethione aminoethyl” compound is?

The patent’s claims (as organized in the application) treat the chroman-imidazolethione-aminoethyl scaffold as a core structure that can be varied by substituting defined groups (according to the claim definitions). Those substituents are part of what makes each claimed compound distinct. [1]

What kinds of claim scope are tied to this scaffold?

The application’s claim coverage is structured around:
- Direct compound claims for particular chroman-imidazolethione-aminoethyl analogs, defined by structural features and substitution patterns. [1]
- Claim coverage that extends to variants using the same scaffold framework (i.e., permitted changes in the substituent definitions). [1]

Which elements (substituents/variables) matter for whether a compound falls “within the claims”?

Whether a given “chroman imidazolethione aminoethyl” compound is within claim scope depends on matching the claim’s permitted structural definitions—especially the allowed substituent patterns attached to the chroman/imidazolethione portions and the aminoethyl linkage as defined in the claim language. The patent uses explicit structural/definition language to delineate which analogs count as claimed compounds and which do not. [1]

Are there also claims about uses or compositions, or only the molecule?

WO2004033447A1 includes claims focused on the compounds themselves (the chroman imidazolethione aminoethyl scaffold and specified variants). The provided information does not include the full text of each claim and therefore does not let me reliably list the exact use/composition claim categories tied to those compounds without risking inaccuracies. [1]

Where can you read the exact claim wording?

To see precisely what is claimed (and which substituent definitions and ranges are used), the authoritative source is the published patent text for WO2004033447A1, including the claims section. [1]

---

Sources
[1] https://patents.google.com/patent/WO2004033447A1/en



Other Questions About Compound :

patent compound extraction midwest compound most affordable tirzepatide compound soma compound cost patent exemptions in pharmacy compounding Carisoma compound alternative? Which nce databases offer global compound intelligence?